Filippo Montemurro, Senior Medical Director at Roche, shared on X about a recent paper by Fatima Cardoso et al. published on NEJM:
“Interesting to see that also placebo has activity in reducing Vasomotor Symptoms from Endocrine Therapy for Breast Cancer. Would this point at a space for non pharmacological interventions? | New England Journal of Medicine.”
Title: Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
Authors: Fatima Cardoso, Susanne Parke, Donal J. Brennan, Paula Briggs, Gilbert Donders, Nick Panay, Nazanin Haseli-Mashhadi, Michael Block, Cecilia Caetano, Maja Francuski, Claudia Haberland, Kaisa Laapas, Christian Seitz, Lineke Zuurman
More posts featuring Filippo Montemurro.